PL1761514T3 - Nowe tetracykliczne pochodne tetrahydrofuranu - Google Patents
Nowe tetracykliczne pochodne tetrahydrofuranuInfo
- Publication number
- PL1761514T3 PL1761514T3 PL05752829T PL05752829T PL1761514T3 PL 1761514 T3 PL1761514 T3 PL 1761514T3 PL 05752829 T PL05752829 T PL 05752829T PL 05752829 T PL05752829 T PL 05752829T PL 1761514 T3 PL1761514 T3 PL 1761514T3
- Authority
- PL
- Poland
- Prior art keywords
- tetrahydrofuran derivatives
- novel tetracyclic
- tetracyclic tetrahydrofuran
- novel
- derivatives
- Prior art date
Links
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical class C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2004051105 | 2004-06-14 | ||
| PCT/EP2005/052706 WO2005121113A1 (en) | 2004-06-14 | 2005-06-13 | Novel tetracyclic tetrahydrofuran derivatives |
| EP05752829A EP1761514B1 (en) | 2004-06-14 | 2005-06-13 | Novel tetracyclic tetrahydrofuran derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1761514T3 true PL1761514T3 (pl) | 2009-01-30 |
Family
ID=34957878
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05752829T PL1761514T3 (pl) | 2004-06-14 | 2005-06-13 | Nowe tetracykliczne pochodne tetrahydrofuranu |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20070197525A1 (pl) |
| EP (1) | EP1761514B1 (pl) |
| JP (1) | JP2008502649A (pl) |
| CN (1) | CN1968942B (pl) |
| AR (1) | AR049512A1 (pl) |
| AT (1) | ATE402932T1 (pl) |
| AU (1) | AU2005251948A1 (pl) |
| CA (1) | CA2567847A1 (pl) |
| DE (1) | DE602005008596D1 (pl) |
| DK (1) | DK1761514T3 (pl) |
| ES (1) | ES2311228T3 (pl) |
| PL (1) | PL1761514T3 (pl) |
| PT (1) | PT1761514E (pl) |
| TW (1) | TW200612899A (pl) |
| WO (1) | WO2005121113A1 (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2604165A1 (en) * | 2005-05-26 | 2006-11-30 | Janssen Pharmaceutica N.V. | Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives and their use as a medicament |
| EP2727585A1 (en) | 2006-05-16 | 2014-05-07 | Takeda Pharmaceutical Company Limited | In-vivo screening method |
| EP2789338A3 (en) | 2007-11-15 | 2015-01-14 | Takeda Pharmaceutical Company Limited | Condensed pyridine derivate and use thereof |
| MX2011006463A (es) | 2008-12-19 | 2011-07-20 | Supernus Pharmaceuticals Inc | Metodo de tratamiento de agresion. |
| WO2011123497A1 (en) | 2010-03-31 | 2011-10-06 | Supernus Pharmaceuticals Inc. | Stabilized formulations of cns compounds |
| CN103874697A (zh) * | 2011-08-03 | 2014-06-18 | 协和发酵麒麟株式会社 | 二苯并氧杂*衍生物 |
| WO2013189920A1 (en) | 2012-06-19 | 2013-12-27 | Ucb Pharma S.A. | New compound based on cinchona alkaloïds for use in asymmetric michael addition |
| US20210052600A1 (en) | 2017-12-27 | 2021-02-25 | Takeda Pharmaceutical Company Limited | Therapeutic agents for stress urinary incontinence and incotinence of feces |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3507920A (en) * | 1964-10-16 | 1970-04-21 | Sterling Drug Inc | Hydroxydibenzo(a,d)cyclohepten-5-ones and esters and ethers thereof |
| US3565956A (en) * | 1964-10-16 | 1971-02-23 | Sterling Drug Inc | Amino-lower-alkoxy-5-alkylidene-dibenzo(a,d)cycloheptenes |
| US3562331A (en) * | 1964-10-16 | 1971-02-09 | Sterling Drug Inc | Amino-lower-alkoxy-dibenzo(a,d)cycloheptene-5-carbinols |
| US3350405A (en) * | 1964-10-16 | 1967-10-31 | Sterling Drug Inc | Amino-lower-alkoxy-dibenzo [a, d] cyclohepten-5-ones and 10, 11-dihydro derivatives thereof |
| US3812119A (en) * | 1969-11-21 | 1974-05-21 | Ciba Geigy Corp | Dibenzocycloheptenes |
| ES2196328T3 (es) * | 1996-04-12 | 2003-12-16 | Janssen Pharmaceutica Nv | Derivados de tetrahidrofurano tetraciclicos sustituidos. |
| UA52778C2 (uk) * | 1997-10-10 | 2003-01-15 | Янссен Фармацевтика Н.В. | Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі |
| KR20050044329A (ko) * | 2001-12-07 | 2005-05-12 | 얀센 파마슈티카 엔.브이. | 트랜스-융합된3,3a,8,12b-테트라히드로-2H-디벤조[3,4:6,7]시클로헵타[1,2-b]푸란 유도체의 제조 |
-
2005
- 2005-06-13 ES ES05752829T patent/ES2311228T3/es not_active Expired - Lifetime
- 2005-06-13 EP EP05752829A patent/EP1761514B1/en not_active Expired - Lifetime
- 2005-06-13 AR ARP050102402A patent/AR049512A1/es not_active Application Discontinuation
- 2005-06-13 JP JP2007515942A patent/JP2008502649A/ja active Pending
- 2005-06-13 DE DE602005008596T patent/DE602005008596D1/de not_active Expired - Lifetime
- 2005-06-13 TW TW094119426A patent/TW200612899A/zh unknown
- 2005-06-13 US US11/570,433 patent/US20070197525A1/en not_active Abandoned
- 2005-06-13 CA CA002567847A patent/CA2567847A1/en not_active Abandoned
- 2005-06-13 AT AT05752829T patent/ATE402932T1/de active
- 2005-06-13 CN CN2005800194190A patent/CN1968942B/zh not_active Expired - Fee Related
- 2005-06-13 PT PT05752829T patent/PT1761514E/pt unknown
- 2005-06-13 WO PCT/EP2005/052706 patent/WO2005121113A1/en not_active Ceased
- 2005-06-13 AU AU2005251948A patent/AU2005251948A1/en not_active Abandoned
- 2005-06-13 PL PL05752829T patent/PL1761514T3/pl unknown
- 2005-06-13 DK DK05752829T patent/DK1761514T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| DE602005008596D1 (de) | 2008-09-11 |
| US20070197525A1 (en) | 2007-08-23 |
| ES2311228T3 (es) | 2009-02-01 |
| JP2008502649A (ja) | 2008-01-31 |
| EP1761514A1 (en) | 2007-03-14 |
| WO2005121113A1 (en) | 2005-12-22 |
| AR049512A1 (es) | 2006-08-09 |
| CA2567847A1 (en) | 2005-12-22 |
| TW200612899A (en) | 2006-05-01 |
| EP1761514B1 (en) | 2008-07-30 |
| PT1761514E (pt) | 2008-10-28 |
| DK1761514T3 (da) | 2008-12-01 |
| CN1968942A (zh) | 2007-05-23 |
| CN1968942B (zh) | 2011-06-15 |
| AU2005251948A1 (en) | 2005-12-22 |
| ATE402932T1 (de) | 2008-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL180962A0 (en) | Novel thiophene derivatives | |
| TWI369356B (en) | Tetrahydropyridoindole derivatives | |
| IL180481A0 (en) | Aryl-pyridine derivatives | |
| IL180331A0 (en) | 3-carbamoyl - 2 - pyridone derivative | |
| ZA200610102B (en) | Pyrrazolo-pyrimidine derivatives | |
| IL183140A0 (en) | Substituted benzoquinolizine derivatives | |
| ZA200703172B (en) | Imidazo-benzodiazepine derivatives | |
| IL183594A0 (en) | Phenyl-piperazin methanone derivatives | |
| IL183142A0 (en) | New pyridothienopyrimidine derivatives | |
| AP2074A (en) | New 4-benzylidene-piperidin derivatives | |
| IL183141A0 (en) | New pyridothienopyrimidine derivatives | |
| GB0414272D0 (en) | OsK1 derivatives | |
| IL177204A0 (en) | Novel 4-benzimidazol -2-ylpyridazin -3- one derivatives | |
| PL1761514T3 (pl) | Nowe tetracykliczne pochodne tetrahydrofuranu | |
| IL179444A0 (en) | 4-phenyl-pyrimidine-2-carbonitrile derivatives | |
| TWI346109B (en) | 4-amino-5-cyanopyrimidine derivatives | |
| IL182001A0 (en) | 2-acylaminothiazole derivatives | |
| ZA200703442B (en) | Proline derivatives | |
| HUP0402371A2 (en) | Novel 125-i-labeled amino-quinoline derivatives | |
| GB0418566D0 (en) | Tropane derivatives | |
| GB0422397D0 (en) | 3-Cyano-Quinoline derivatives | |
| GB0405905D0 (en) | Azaquinazoline derivatives | |
| GB0404801D0 (en) | Bicyclic derivatives |